CIK 0001841330 · <br>Emerging growth company
Pasithea Therapeutics Corp.
Sign in to watch- Ticker
- KTTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851591963
- Phone
- (702) 514-4174
- Business address
- 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Regulation FD disclosure · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 3 of 18 · 344 filings